Drug Profile
Fluticasone propionate - GSK
Alternative Names: Flixotide; Flixotide Evohaler; Flixotide NebulesLatest Information Update: 08 Jul 2023
Price :
$50
*
At a glance
- Originator Glaxo Wellcome SA
- Developer GSK
- Class Analgesics; Androstadienes; Anti-inflammatories; Antiallergics; Antiasthmatics; Eye disorder therapies; Fluorinated steroids; Glucocorticoids; Inorganic sulfur compounds; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Asthma
Most Recent Events
- 30 Nov 2020 No development reported - Phase-III for Asthma (In the elderly, In adults) in China (Inhalation)
- 03 Apr 2019 Chemical structure information added
- 28 Sep 2016 Discontinued - Phase-II for Asthma in New Zealand (Inhalation)